Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis

Clinical Rheumatology

Volumn 27, Issue 9, 2008, Pages 1119-1125

  Bodur, H ^a   Ataman, S ^b   Akbulut, L ^a   Evcik, D ^c   Kavuncu, V ^c   Kaya, T ^d   Gunaydin R ^d   Kuran, B ^e   Kotevoglu N ^e   Bal, A ^f   Aydog E ^f   Altay, Z ^g   Ugurlu H ^h   Kocabas H ^h   Olmez N ⁱ   Yazgan, P ^j   Gursoy S ^k   Madenci, E ^k   Ozel S ^l   Delialioglu S U ^l  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d Izmir Ataturk Training and Research Hospital   (Turkey)

^e SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^g INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^h SELCUK UNIVERSITY   (Turkey)

ⁱ ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^j HARRAN UNIVERSITY   (Turkey)

^k GAZIANTEP UNIVERSITY   (Turkey)

^l Training Hospital   (Turkey)

more..

Author keywords

Ankylosing spondylitis; Clinical characteristics; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; LEFLUNOMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METHOTREXATE; PENICILLAMINE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTHROPLASTY; ARTICLE; BONE EROSION; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG USE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL STATUS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYNOVECTOMY; TURKEY (REPUBLIC);

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; RHEUMATOID FACTOR; SPONDYLITIS, ANKYLOSING; SULFASALAZINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48449104322     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0877-1     Document Type: Article

References (28)

1. Akar S, Birlik M, Gurler O et al (2004) The prevalence of rheumatoid arthritis in an urban population of Izmir Turkey. Clin Exp Rheumatol 22:416-420
2. Kacar C, Gilgil E, Tuncer T et al (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24(3):212-214
3. Onen F, Akar S, Birlik M et al (2006) Prevalence of ankylosing spondylitis and related spondyloarthritis in an urban area of Izmir Turkey. EULAR, Amsterdam
4. Arnett F, Edworthy S, Bloch D et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
5. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
6. Gülfe A, Geborek P, Saxne T (2005) Response criteria for rheumatoid arthritis in clinical practice: How useful are they. Ann Rheum Dis 64:1186-1189
7. Kucukdeveci AA, Sahin H, Ataman S (2004) Issues in cross-cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 51(1):14-19
8. Hochberg MC, Chang RW, Dwash I et al (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498-502
9. Sany J, Bourgeois P, Saraux A et al (2004) Characteristics of patients with rheumatoid arthritis in France: A study of 1109 patients managed by hospital based rheumatologist. Ann Rheum Dis 63:1235-1240
10. Heuft-Dorenbosch L, Spoorenberg A, von Tubergen A et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127-132
11. Bostan EE, Borman P, Bodur H (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23(3):121-126
12. Akkoç Y, Karatepe AG, Asar S et al (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: Reliability and validity. Rheumatol Int 25(4):280-284
13. Yanik B, Gürsel YK, Kutlay S et al (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: Functional assessment in AS. Clin Rheumatol 24(1):41-47
14. Braun J, Dougados M, Sieper J et al (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65:316-320
15. Conover WJ (1980) Practical nonparametric statistics, 2nd edn. Wiley, New York, p 229-239
16. Çalgüneri M, Üreten K, Öztürk A et al (2006) Extraarticular manifestation of rheumatoid arthritis: Results of a university hospital of 562 patients in Turkey. Clin Exp Rheumatol 24(3):305-308
17. Carmona L, Gonzalez-Alvaro I, Balsa A (2003) Rheumatoid arthritis in Spain: Occurrence of extraarticular manifestations and estimates of disease severity. Ann Rheum Dis 62:897-900
18. Aletaha D, Smolen JS (2002) The rheumatoid arthritis patient in the clinic: Comparing more than 1300 consecutive DMARD courses. Rheumatology 41:1367-1374
19. Zink A, Listing J, Niewerth M et al (2001) The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis. Ann Rheum Dis 60:207-213
20. Baek HJ, Shin KC, Lee YJ et al (2004) Clinical features of adult-onset ankylosing spondylitis in Korean patients: Patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD. Rheumatology 43:1526-1531
21. Uppal SS, Abraham M, Chowdhury RI et al (2006) Ankylosing spondylitis and undifferentiated spondyloarthritis in Kuwait: A comparison between Arabs and South Asians. Clin Rheumatol 25(2):219-224
22. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63:535-543
23. Sampaio-Barros PD, Bertolo MB, Kraemer MH et al (2001) Primary ankylosing spondylitis: Patterns of disease in a Brazilian population of 147 patients. J Rheumatol 28(3):560-565
24. Spoorenberg A, van Tubergen A, Landewe R et al (2005) Measuring disease activity in ankylosing spondylitis: Patient and physician have different perspectives. Rheumatology 44:789-795
25. Maksymowych WP (2004) Ankylosing spondylitis. Not just another pain in the back. Can Fam Physician 50:257-262
26. Dagfinrud H, Kjeken I, Mowinckel P et al (2005) Impact of functional impairment in ankylosing spondylitis: Impairment, activity limitation, and participation restriction. J Rheumatol 32:516-523
27. Oniankitan O, Ranaivo N, Carton L et al (2005) Poorly and well controlled spondyloarthropathies: A comparison of 2 groups of patients. J Rheumatol 32:77-79
28. Akkoç N, van der Linden S, Khan MA (2006) Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy. Best Pract Res Clin Rheumatol 20(3):539-557